IN2013MU01154A - - Google Patents

Info

Publication number
IN2013MU01154A
IN2013MU01154A IN1154MU2013A IN2013MU01154A IN 2013MU01154 A IN2013MU01154 A IN 2013MU01154A IN 1154MU2013 A IN1154MU2013 A IN 1154MU2013A IN 2013MU01154 A IN2013MU01154 A IN 2013MU01154A
Authority
IN
India
Prior art keywords
cyclobenzaprine
salts
pharmaceutical compositions
relates
present
Prior art date
Application number
Inventor
Girish Kumar Jain
Rahul Sudhakar Dabre
Vivek Dubey
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1154MU2013 priority Critical patent/IN2013MU01154A/en
Priority to PCT/IB2014/060055 priority patent/WO2014167440A1/en
Publication of IN2013MU01154A publication Critical patent/IN2013MU01154A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to process for preparation of modified release pharmaceutical compositions of cyclobenzaprine or salts thereof. In particular, the present invention relates to process for preparing modified release pharmaceutical compositions comprising unit dosage form of cyclobenzaprine or salts thereof in the form of uncoated units. The composition may provide extended and specific release of cyclobenzaprine or salts thereof to achieve therapeutically effective plasma concentration over a period of 24 hours to treat muscle spasm associated with painful musculoskeletal conditions when administered to a patient in need thereof.
IN1154MU2013 2013-03-26 2014-03-22 IN2013MU01154A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1154MU2013 IN2013MU01154A (en) 2013-03-26 2014-03-22
PCT/IB2014/060055 WO2014167440A1 (en) 2013-03-26 2014-03-22 Modified release pharmaceutical compositions of cyclobenzaprine or salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1154MU2013 IN2013MU01154A (en) 2013-03-26 2014-03-22

Publications (1)

Publication Number Publication Date
IN2013MU01154A true IN2013MU01154A (en) 2015-04-24

Family

ID=54395426

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1154MU2013 IN2013MU01154A (en) 2013-03-26 2014-03-22

Country Status (1)

Country Link
IN (1) IN2013MU01154A (en)

Similar Documents

Publication Publication Date Title
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
UA115139C2 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
MX2013011908A (en) Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors.
BR112015022197A8 (en) use of a compound for the manufacture of a medicament or pharmaceutical composition for treating cataplexy
IN2015DN03219A (en)
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
BR112014004435A2 (en) rock kinase inhibitors
SA113340494B1 (en) Composition for treating metabolic disorders
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
TW201129361A (en) Methods for treating pain
MX2014011843A (en) Compounds for use in the treatment of neuroblastoma, ewing's sarcoma or rhabdomyosarcoma.
GB201115977D0 (en) Neurodevelopmental disorders
IN2013MU01154A (en)
MX2020005438A (en) Abuse deterrent morphine sulfate dosage forms.
IN2013MU01155A (en)
MX2016001177A (en) Treatment of multiple sclerosis with combination of laquinimod and flupirtine.
MX2014000870A (en) Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2- ylidene)-1h-benzimidazol-5-amine for treating retinal diseases.
IN2014MU01184A (en)
IN2014MU01185A (en)
SG10201809280PA (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
IN2013MU01240A (en)
IN2013MU01241A (en)
IN2013MU01242A (en)